Author: Sarah Gaskill, MD, FAAp, FACS
The 44th Annual Meeting of the Joint Section on Pediatric Neurological Surgery was held December 8–11, 2015, in Seattle, Washington. Hosted by Drs. Sam Browd and Amy Lee, the theme was Innovation, Invention and the Future of Pediatric Neurosurgery. We are pleased to announce the meeting had a record attendance of nearly 400 people. A total of 67 oral presentations, 20 top posters, and 46 e-posters were presented.
The Raimondi Lecture was given by Rick R. Holley, chief executive officer of Plum Creek, a premier land and timber company dedicated to responsible environmental stewardship, community engagement, and innovation.
The AAP/SONS Lecture was delivered by Wendy Sue Swanson, MD, MBE, a pediatrician and executive director of digital health at Seattle Children’s Hospital. She is also the author of the excellent Seattle Mama Doc Blog. Dr. Swanson works to revolutionize health communications by using social and digital media to bridge the gap between parents and doctors.
The prestigious Ingraham Award was given to A. Leland Albright, MD, for his outstanding contributions to our field. Dr. Albright’s work throughout his career in the United States and Africa is a tribute to our profession, and the Ingraham Award was a well-deserved honor.
Three outstanding clinical symposia were presented: Hydrocephalus: Shunting vs ETV (Drs. Kulkarni, Riva-Cambrin, and Klimo); Concussions: Controversies in Management (Drs. Johnston, Duhaime, and Ellenbogen); and Advances in Tumor Technology (Drs. Ellenbogen, Olson, and Holland). We invite you to join us next year at the 45th Annual Meeting of the Joint Section on Pediatric Neurological Surgery, taking place in Orlando, Florida, December 5-8, 2016.
Looking ahead, the Matson Lecture will be given by Cesar V. Borlongan, PhD, at the AANS Annual Meeting this May. Dr. Borlongan is distinguished professor and vice-chairman of research at the University of South Florida Department of Neurosurgery and Brain Repair, and Director of the Center of Excellence for Aging and Brain Repair. He is a world leader in stem cell research for stroke therapy. His highly innovative translational bench to clinic research has led to five FDA-approved clinical trials of cell transplantation in stroke, including the world’s first cell therapy in stroke patients. There will be a reception to honor Dr. Borlongan following his lecture.